Tralokinumab: Exploring the Promise of LP 0162 and CAT-354 Tralokinumab, previously known as LP 0162 and CAT-354, represents a significant treatment for severe dermatitis. This humanized antibody targets IL-13, https://prbookmarkingwebsites.com/story28555720/text